Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 53
16
Diseases
15
Unique genes
0.346
Avg. similarity score
Clapo syndrome
Most-connected disease (11 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Clapo syndrome
Cloves syndrome
Congenital intestinal duplication
Congenital macrodactylia
Congenital malformation syndromes involving early overgrowth
Capillary-lymphatic-venous malformation
Congenital hemihypertrophy
Diaphragmatic malformations
Hemifacial myohyperplasia
Hemihyperplasia multiple lipomatosis syndrome
Vascular malformation
Weaver syndrome
Charcot-Marie-Tooth disease type 2A1
Charcot-Marie-Tooth disease type 4C
Cohen-gibson syndrome
Upper extremity deformity, congenital
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Clapo syndrome | 11 | 11 | 1 |
| Cloves syndrome | 11 | 11 | 1 |
| Congenital intestinal duplication | 11 | 11 | 1 |
| Congenital macrodactylia | 9 | 9 | 1 |
| Congenital malformation syndromes involving early overgrowth | 9 | 9 | 1 |
| Capillary-lymphatic-venous malformation | 5 | 5 | 2 |
| Congenital hemihypertrophy | 5 | 5 | 4 |
| Diaphragmatic malformations | 5 | 5 | 5 |
| Hemifacial myohyperplasia | 5 | 5 | 1 |
| Hemihyperplasia multiple lipomatosis syndrome | 5 | 5 | 1 |
| Vascular malformation | 5 | 5 | 3 |
| Weaver syndrome | 5 | 5 | 5 |
| Charcot-Marie-Tooth disease type 2A1 | 1 | 1 | 1 |
| Charcot-Marie-Tooth disease type 4C | 1 | 1 | 1 |
| Cohen-gibson syndrome | 1 | 1 | 1 |
| Upper extremity deformity, congenital | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| PIK3CA | 12 / 16 | Capillary-lymphatic-venous malformation, Clapo syndrome, Cloves syndrome, Congenital hemihypertrophy and 8 more |
| EED | 2 / 16 | Cohen-gibson syndrome, Weaver syndrome |
| EZH2 | 2 / 16 | Upper extremity deformity, congenital, Weaver syndrome |
| KIF1B | 2 / 16 | Charcot-Marie-Tooth disease type 2A1, Congenital hemihypertrophy |
| SH3TC2 | 2 / 16 | Charcot-Marie-Tooth disease type 4C, Congenital hemihypertrophy |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| PKMTs methylate histone lysines | Reactome | 4 / 71 | 45.1× | 1.46e-6 | 6.77e-5 ✓ sig. |
| Transcriptional Regulation by E2F6 | Reactome | 3 / 35 | 68.6× | 1.01e-5 | 3.38e-4 ✓ sig. |
| Regulation of PTEN gene transcription | Reactome | 3 / 53 | 45.3× | 3.56e-5 | 9.62e-4 ✓ sig. |
| PI3K/AKT activation | Reactome | 2 / 9 | 178× | 5.22e-5 | 1.32e-3 ✓ sig. |
| VEGFA-VEGFR2 Pathway | Reactome | 3 / 62 | 38.7× | 5.70e-5 | 1.42e-3 ✓ sig. |
| PRC2 methylates histones and DNA | Reactome | 3 / 73 | 32.9× | 9.30e-5 | 2.11e-3 ✓ sig. |
| Bacterial invasion of epithelial cells | KEGG | 3 / 78 | 30.8× | 1.13e-4 | 2.48e-3 ✓ sig. |
| PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases | Reactome | 2 / 14 | 114× | 1.31e-4 | 2.80e-3 ✓ sig. |
| Polycomb repressive complex | KEGG | 3 / 83 | 28.9× | 1.36e-4 | 2.88e-3 ✓ sig. |
| EPHA-mediated growth cone collapse | Reactome | 2 / 20 | 80.1× | 2.73e-4 | 4.98e-3 ✓ sig. |
| Regulation of signaling by CBL | Reactome | 2 / 21 | 76.3× | 3.02e-4 | 5.39e-3 ✓ sig. |
| Oxidative Stress Induced Senescence | Reactome | 3 / 125 | 19.2× | 4.57e-4 | 7.43e-3 ✓ sig. |
| MicroRNAs in cancer | KEGG | 4 / 311 | 10.3× | 4.80e-4 | 7.72e-3 ✓ sig. |
| HCMV Early Events | Reactome | 3 / 135 | 17.8× | 5.72e-4 | 8.86e-3 ✓ sig. |
| Yersinia infection | KEGG | 3 / 138 | 17.4× | 6.10e-4 | 9.32e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| facultative heterochromatin formation | GO:0140718 | 3 / 7 | 534× | 1.46e-8 | 2.38e-6 ✓ sig. |
| liver development | GO:0001889 | 3 / 87 | 43.0× | 4.26e-5 | 1.60e-3 ✓ sig. |
| positive regulation of protein serine/threonine kinase activity | GO:0071902 | 2 / 15 | 166× | 6.28e-5 | 2.13e-3 ✓ sig. |
| cardiac muscle tissue development | GO:0048738 | 2 / 24 | 104× | 1.64e-4 | 4.39e-3 ✓ sig. |
| chromatin organization | GO:0006325 | 4 / 449 | 11.1× | 3.64e-4 | 7.65e-3 ✓ sig. |
| oligodendrocyte differentiation | GO:0048709 | 2 / 45 | 55.4× | 5.84e-4 | 1.06e-2 ✓ sig. |
| endothelial cell migration | GO:0043542 | 2 / 48 | 51.9× | 6.64e-4 | 1.15e-2 ✓ sig. |
| determination of bilateral symmetry | GO:0009855 | 1 / 1 | 1,246× | 8.03e-4 | 1.30e-2 ✓ sig. |
| angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure | GO:0001998 | 1 / 1 | 1,246× | 8.03e-4 | 1.30e-2 ✓ sig. |
| alpha-beta T cell lineage commitment | GO:0002363 | 1 / 1 | 1,246× | 8.03e-4 | 1.30e-2 ✓ sig. |
| mitotic cleavage furrow formation | GO:1903673 | 1 / 1 | 1,246× | 8.03e-4 | 1.30e-2 ✓ sig. |
| regulation of peptidyl-serine phosphorylation | GO:0033135 | 1 / 1 | 1,246× | 8.03e-4 | 1.30e-2 ✓ sig. |
| regulation of RNA polymerase II regulatory region sequence-specific DNA binding | GO:1903025 | 1 / 1 | 1,246× | 8.03e-4 | 1.30e-2 ✓ sig. |
| response to butyrate | GO:1903544 | 1 / 1 | 1,246× | 8.03e-4 | 1.30e-2 ✓ sig. |
| hepatocyte homeostasis | GO:0036333 | 1 / 1 | 1,246× | 8.03e-4 | 1.30e-2 ✓ sig. |